Similar Articles
Factors Predicting Falls in Parkinson’s Disease: Investigation of Motor, Non-motor Findings and Different Dual Task Activities
Zeynep Tüfekçioğlu, Burcu Ersöz Hüseyinsinoğlu, Emrah Zirek, Başar Bilgiç, Hakan Gürvit, Haşmet Hanağasi
DOI: 10.4274/tnd.2019.71235
The Use of Clobazam as Add-on Treatment in Resistant Epilepsy: Our Retrospective Clinical Data
Damla Çetinkaya, Seher Naz Yeni
DOI: 10.4274/tnd.2019.22755
Investigation of Adaptation to Successive Postural Perturbations in Patients with Multiple Sclerosis
Yeliz Salcı, Ecem Karanfil, Ender Ayvat, Ayla Fil Balkan, Jale Karakaya, Songül Aksoy, Kadriye Armutlu, Aslı Kurne, Rana Karabudak
DOI: 10.4274/tnd.2019.34392
Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study
Canan Duman İlki, Tuncay Gündüz, Murat Kürtüncü, Zuhal Yapıcı, Serra Sencer, Mefküre Eraksoy
DOI: 10.4274/tnd.2019.77010
Serum Uric Acid Level, Alzheimer-type Dementia and Variation
Joob Beuy, Viroj Wiwanitkit
DOI: 10.4274/tnd.2019.30643
Neuroprotective Treatments in Parkinson’s Disease
Elif Çınar, Gul Yalçın Çakmaklı, Banu Cahide Tel
DOI: 10.4274/tnd.2019.01205
The Value of Autoantibody and Viral Serologic Examinations in the Differential Diagnosis of Multiple Sclerosis and Stroke
Ahmet Şair, Utku Ogan Akyıldız, Berna Korkmazgil, Nefati Kıylıoğlu
DOI: 10.4274/tnd.2019.09735
Determination of Lipid Profile and Anthropometric Measurements of Multiple Sclerosis Patients: A Controlled Descriptive Study
Gülşen Delikanlı Akbay, Erdinç Karakullukçu, Aslı Akyol Mutlu, Halit Tanju Besler
DOI: 10.4274/tnd.2019.33341
Susceptibility to Juvenile Myoclonic Epilepsy Associated with the EFHC1 Gene: First Case Report in Turkey
Pınar Bekdik Şirinocak, Barış Salman, Fatma Yeşim Kesim, Nerses Bebek, Betül Baykan, Sibel Aylin Ugur İşeri
DOI: 10.4274/tnd.2019.61214
Seizures with Autonomic Symptoms and Sudden Unexpected Death in Epilepsy (SUDEP)
Rabia Gökçen Gözübatık Çeli, Çiğdem Özkara
DOI: 10.4274/tnd.2019.56254
Evaluation of C-reactive Protein/Albumin Ratio According to Stage in Patients with Idiopathic Parkinson Disease
Tamer Yazar, Hülya Olgun Yazar
DOI: 10.4274/tnd.2019.13334
Screening Inherited Metabolic Disorder in Children with Intellectual Disability and Epilepsy
Pembe Soylu Üstkoyuncu, Ahmet Sami Güven, Hatice Gamze Poyrazoğlu, Songül Gökay, Fatih Kardaş, Mustafa Kendirci, İkbal Gökçek, Yasemin Altuner Torun
DOI: 10.4274/tnd.2019.82608
The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis
Rabia Gökçen Gözübatık Çelik, Musa Öztürk, Serap Altın, Mesrure Köseoğlu, Hande Sariahmetoğlu, Mesude Tütüncü, Aysun Soysal
DOI: 10.4274/tnd.2019.04207
Quality of Life in Patients with Drug Resistant Epilepsy
Hari Krishan Aggarwal, Deepak Jain, Avina Bishnoi
DOI: 10.4274/tnd.2019.31391
What is the Effect of Accompanying Ankylosing Spondylitis in Treatment of Multiple Sclerosis? Is there a Resistance
Ezgi Akyıldız Tezcan, Hakan Ekmekçi, Gökhan Özdemir, Haluk Gümüş, Şerefnur Öztürk
DOI: 10.4274/tnd.2019.93206
Coexistence of Ankylosing Spondylitis and Multiple Sclerosis: Trigger with TNF-alpha Antagonist Therapy or Coincidental?
Bahar Say, Ufuk Ergün
DOI: 10.4274/tnd.2019.87513
Prognostic Value of Serum Neurofilaments in Patients with Clinically Isolated Syndromes
İpek Güngör Doğan
DOI: 10.4274/tnd.2019.97720
The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results
Sami Ömerhoca, Sinem Yazıcı Akkaş, Zerrin Yıldırım Haşimoğlu, Sebatiye Erdoğan, Nilüfer Kale
DOI: 10.4274/tnd.2019.75725
Assessment of Serum Uric Acid Levels According to Sex and Stage for Patients with Alzheimer-type Dementia
Tamer Yazar, Hülya Olgun Yazar
DOI: 10.4274/tnd.2019.85698
Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
Halil Önder
DOI: 10.4274/tnd.2019.05925